Introduction {#sec0005}
============

Antiseptic mouthwashes have been widely used as a standard measure before routine dental treatment, especially preoperatively.[@bib0005], [@bib0010] They have an essential role in reducing the number of microorganisms in the oral cavity.[@bib0015] Recent publications have suggested that rinsing the oral cavity may control and reduce the risk of transmission of SARS-CoV-2.[@bib0020], [@bib0025] However, specific evidence for the safety and efficacy of the use of antiseptic mouthwashes in COVID-19 positive patients is lacking and unclear, so this paper aims to provide a comprehensive review of the current recommendations on the use of mouthwashes against the COVID-19 pandemic and to analyse the advantages and disadvantages of most conventional antiseptic mouthwashes used in dentistry.

Pathogenesis of coronavirus disease 2019 {#sec0010}
========================================

Coronaviruses are a group of enveloped RNA viruses that present a typical structure with the "spike protein" in its membrane envelope.[@bib0030], [@bib0035] The interaction between this protein and angiotensin-converting enzyme 2 (ACE2) receptors is responsible for the entry of the virus into cells.[@bib0040] The distribution of ACE2 receptors in different parts of the body may indicate possible routes of infection.[@bib0045], [@bib0050] The membrane bound to ACE2 is found in different tissue cells, including mucosal tissues, gingiva, non-keratinising squamous epithelium, and epithelial cells of the tongue and salivary glands.[@bib0040], [@bib0055] A high SARS-CoV-2 viral load has also been detected in saliva,[@bib0060] and it its presence has even been suggested in periodontal pockets.[@bib0065] These findings agree with previous investigations that have suggested that virus transmission can be closely connected with saliva interactions[@bib0070], [@bib0075] making oral tissues a possible reservoir from which SARS-CoV-2 transmission may occur during coughing, sneezing, talking, and even during dental care.[@bib0020], [@bib0060], [@bib0080]

Oral antiseptics used against viral infections {#sec0015}
==============================================

Mouthwashes are widely used solutions for rinsing the mouth, especially before oral surgery, due to their ability to reduce the number of microorganisms in the oral cavity[@bib0005], [@bib0010] and colony-forming units in dental aerosols.[@bib0015] Although there is still no clinical evidence that the use of mouthwashes could prevent SARS-CoV-2 transmission, the American Dental Association (ADA)[@bib0085] and the Center for Disease Control and Prevention (CDC)[@bib0090] have recommended the use of preprocedural mouthwashes before oral procedures.

Chlorhexidine (CHX) {#sec0020}
-------------------

CHX is a broad-spectrum antiseptic that acts against Gram-positive and Gram-negative bacteria, aerobes, facultative anaerobes, and fungus by increasing the permeability of the bacterial cell wall, causing its lysis.[@bib0095], [@bib0100] It is used in dentistry to reduce dental plaque and treat periodontal disease.[@bib0105]

Evidence indicates an in vitro effect against lipid-enveloped viruses such as influenza A, parainfluenza, herpes virus 1, cytomegalovirus, and hepatitis B.[@bib0110] Although COVID-19 is an enveloped virus, 0.12% CHX gluconate was suggested to have little or no effect against coronaviruses when compared with other mouthwashes.[@bib0020], [@bib0115], [@bib0120] However, Yoon et al[@bib0030] found SARS-CoV-2 suppression for two hours after using 15 ml 0.12% CHX once, suggesting that its use would be beneficial for the control of COVID-19 transmission.

Hydrogen peroxide (H~2~O~2~) {#sec0025}
----------------------------

H~2~O~2~ has been used in dentistry alone or combined with salts since the start of the century.[@bib0125] As a mouthwash, it is an odourless, clear, and colourless liquid.[@bib0130] Lack of an adverse soft tissue effect was found in many studies of 1%--1.5% H~2~O~2~ used as a daily rinse over two years' follow-up.[@bib0135], [@bib0140]

An in vitro study found that 3% H~2~O~2~ effectively inactivated adenovirus types 3 and 6, adeno-associated virus type 4, rhinoviruses 1A, 1B, and type 7, myxoviruses, influenza A and B, respiratory syncytial virus, strain long, and coronavirus strain 229E within 1--30 minutes, discovering that coronaviruses and influenza viruses were the most sensitive.[@bib0145] Since SARS-CoV2 is vulnerable to oxidation, preprocedural mouthrinses containing oxidative agents such as 1% H~2~O~2~ have been suggested to reduce the salivary viral load.[@bib0020], [@bib0085]

Cetylpyridinium chloride (CPC) {#sec0030}
------------------------------

CPC is a quaternary ammonium compound that is safe for use in humans.[@bib0150], [@bib0155] CPC 0.05% has been used to reduce dental plaque and gingivitis[@bib0160] as an alternative in patients who develop mucosal irritation and stains related to CHX.[@bib0165] The antiviral effect of CPC has been demonstrated in influenza patients, significantly reducing the duration and severity of cough and sore throat.[@bib0155], [@bib0170] Hypotheses about a possible action over SARS-CoV-2 are based on its lysosomotropic mechanism of action and its ability to destroy viral capsids.[@bib0175] These findings indicate that CPC could be effective against other enveloped viruses such as coronaviruses.

Iodopovidone {#sec0035}
------------

Povidone-iodine (PVP-I) is a water-soluble iodine complex that has been widely used as a pre-surgical skin antiseptic and as a mouthwash.[@bib0180] It is typically used in a 1% concentration[@bib0185] for mucositis, prophylaxis of oropharyngeal infections, and prevention of ventilator-associated pneumonia. Its antimicrobial action occurs after free iodine dissociates from polyvinylpyrrolidone, then iodine rapidly penetrates microbes to disrupt proteins and oxidises nucleic acid structures causing microbial death.[@bib0190], [@bib0195] Previously studies have shown that PVP-I has higher virucidal activity than other commonly used antiseptic agents, including CHX and benzalkonium chloride.[@bib0200] It is safe, reporting a prevalence of 0.4% allergy cases,[@bib0205] does not produce tooth or tongue discolouration or taste disturbances[@bib0210] and, unlike alcohol-based products, can be used when using electrocautery.[@bib0215] Its effectiveness has been well demonstrated through many in vitro studies against multiple viruses, including SARS-CoV, MERS-CoV, and influenza virus A (H1N1).[@bib0180], [@bib0200], [@bib0220] Recent investigations have proposed that 0.23% PVP-I mouthwash for at least 15 seconds before procedures may reduce salivary viral load,[@bib0220] indicating its use in COVID-19-positive patients.[@bib0020], [@bib0190], [@bib0225], [@bib0230]

Suggested recommendations {#sec0040}
=========================

Gently gargle for 30 seconds in the oral cavity and 30 seconds in the back of the throat with: 1.5%[@bib0085] or 3%[@bib0235] H~2~O~2~ 15 ml; PVP-I, 0.2%,[@bib0085] 0.4%,[@bib0225] or 0.5%[@bib0230], [@bib0240] 9 ml; 0.12% CHX 15 ml;[@bib0030] or 0.05% CPC 15 ml.[@bib0155], [@bib0175]

Conclusions {#sec0045}
===========

Within the limitations of this brief review and despite little clinical evidence, we suggest the use of preprocedural mouthwashes in dental practice to reduce SARS-CoV-2 viral load from previous dental procedures and to reduce the cross-infection risk while treating patients during the pandemic. Clinical studies, including control subjects and in large scale, are required to evaluate the efficacy of antiseptic mouthwashes on SARS-CoV-2. Research is urgently needed to determine its potential for use against this new virus.
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